Heidi K. Roennest
Executive Office Manager
+45 4526 5050
Symphogen is a private biopharmaceutical company focused in the field of discovery and early clinical development of antibody therapeutics for use in oncology and other significant diseases. Symphogen intends to commercialize its unique platform for generation of high-quality therapeutic antibodies with rare functionalities through partnerships, out-licensing or sale. The Company has collaborations for the development of antibody therapeutics in immuno-oncology with Servier and in the infectious disease area with Genentech.
Inspired by nature, led by science and driven by people, we passionately strive to make that discovery that may have great effect on the lives of patients, their families, and their caregivers.